These complex genomic insights warrant a more nuanced understanding of the phenotypic manifestation of HNF1A gene variants: some alleles are sufficient for early-onset sulfonylurea-responsive diabetes (HNF1A-MODY), although it should be noted that not all carriers of these alleles get early-onset diabetes; not even diabetes at all. This evidence concerns the gene HNF1A and diabetes mellitus.